0

Novogen Ltd (NRT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Publisher Name :
Date: 17-May-2017
No. of pages: 45

Summary

Novogen Ltd (Novogen) is a clinical stage biotechnology company which focuses on the discovery and development of anti-cancer drugs. It develops its products based on two main drug technology platforms, anti-tropomyosins (ATM) and super-benzopyrans (SBP). ATM drugs that target the cancer cell cytoskeleton are being developed for the treatment of melanoma, prostate cancer and neuroblastoma. SBP drugs that target cancer stem cells are being developed for the treatment of ovarian cancer and glioblastoma. The company’s major drug candidates include is Cantrixil (TRX-E-002-1); Trilexium (TRXE-009-1)and Anisina (ATM-3507). Novogen is headquartered in New South Wales, Australia.

Novogen Ltd (NRT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
– The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
– The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
– Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
– Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
– Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of content
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Novogen Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Novogen Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Novogen Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Novogen Acquires Anti-Tropomyosins Drug Technology From Genscreen 12
Partnerships 13
Novogen Enters into Contract Research Agreement with Novotech 13
Novogen to Enter into Co-Development Agreement with Feinstein Institute for Medical Research for Brain Cancer 13
Novogen Enters into Agreement with Genea Biocells 14
Novogen Forms Joint Venture With Yale University 15
Novogen Enters Into Agreement With The Ingham Institute For Applied Medical Research 16
Licensing Agreements 17
Novogen Enters into Licensing Agreement with Genentech for GDC-0084 17
Equity Offering 18
Novogen Raises USD13 Million in Rights Offering of Shares 18
Novogen to Raise USD0.51 Million in Private Placement of Shares 19
Novogen Raises USD12 Million in Private Placement of Shares 20
Novogen to Raise Additional USD1.4 million in Private Placement of Shares 21
Novogen Completes Second Tranche Of Private Placement Of Shares For US$0.14 Million 22
Novogen Completes Rights Offering Of Shares For US$0.8 Million 23
Novogen Completes Private Placement Of Shares For US$2 Million 24
Marshall Edwards Completes Private Placement Of Common Stock For US$2 Million 25
Marshall Edwards Completes Private Placement Of Common Stock For US$2 Million 26
Debt Offering 27
Novogen Completes Third Tranche of Private Placement Of Private Placement Of Note For US$3.7 Million 27
Asset Transactions 28
TR Therapeutics Completes Acquisition Of Glucan Technology Assets From Novogen 28
Pharm-a-Care Labs Completes Acquisition Of Consumer Products Business From Novogen For US$10.8 Million 29
Marshall Edwards Completes Acquisition Of Intellectual Property Portfolio From Novogen 30
Acquisition 31
Novogen Acquires Glioblast for USD1.6 Million 31
Novogen Completes Acquisition Of Triaxial Pharma For US$2 Million 32
Novogen Ltd - Key Competitors 34
Key Employees 35
Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 37
Corporate Communications 37
Mar 10, 2017: Novogen Announces Transformation to a Clinical Stage Organisation Leads to Changes in Management Structure 37
Mar 10, 2017: Novogen: Transformation To A Clinical Stage Organisation Leads To Changes In Management Structure 38
Aug 29, 2016: Novogen Appoints Key Management Personnel To Drive Transition To A Development - Focused Organisation 39
Feb 05, 2016: Novogen Announces Changes to the Board with New Chairman and Deputy Chairman Appointed 40
Product News 41
03/16/2016: Novogen Receives R&D Tax Incentive Cash Refund 41
Product Approvals 42
Aug 11, 2016: Novogen Submits Investigational New Drug (IND) Application to the US FDA For Cantrixil in Ovarian Cancer 42
Clinical Trials 43
Sep 12, 2016: US FDA Approves Investigational New Drug (IND) Application For Cantrixil (TRX-E-002-1) In Ovarian Cancer 43
May 02, 2016: Novogen Provides Update On Development Of Cantrixil 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Novogen Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Novogen Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Novogen Ltd, Deals By Therapy Area, 2011 to YTD 2017 9
Novogen Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Novogen Acquires Anti-Tropomyosins Drug Technology From Genscreen 12
Novogen Enters into Contract Research Agreement with Novotech 13
Novogen to Enter into Co-Development Agreement with Feinstein Institute for Medical Research for Brain Cancer 13
Novogen Enters into Agreement with Genea Biocells 14
Novogen Forms Joint Venture With Yale University 15
Novogen Enters Into Agreement With The Ingham Institute For Applied Medical Research 16
Novogen Enters into Licensing Agreement with Genentech for GDC-0084 17
Novogen Raises USD13 Million in Rights Offering of Shares 18
Novogen to Raise USD0.51 Million in Private Placement of Shares 19
Novogen Raises USD12 Million in Private Placement of Shares 20
Novogen to Raise Additional USD1.4 million in Private Placement of Shares 21
Novogen Completes Second Tranche Of Private Placement Of Shares For US$0.14 Million 22
Novogen Completes Rights Offering Of Shares For US$0.8 Million 23
Novogen Completes Private Placement Of Shares For US$2 Million 24
Marshall Edwards Completes Private Placement Of Common Stock For US$2 Million 25
Marshall Edwards Completes Private Placement Of Common Stock For US$2 Million 26
Novogen Completes Third Tranche of Private Placement Of Private Placement Of Note For US$3.7 Million 27
TR Therapeutics Completes Acquisition Of Glucan Technology Assets From Novogen 28
Pharm-a-Care Labs Completes Acquisition Of Consumer Products Business From Novogen For US$10.8 Million 29
Marshall Edwards Completes Acquisition Of Intellectual Property Portfolio From Novogen 30
Novogen Acquires Glioblast for USD1.6 Million 31
Novogen Completes Acquisition Of Triaxial Pharma For US$2 Million 32
Novogen Ltd, Key Competitors 34
Novogen Ltd, Key Employees 35
Novogen Ltd, Subsidiaries 36

List of Figures
Novogen Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Novogen Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

News

  • Understanding the Need For Travel Vaccination
  • If you are getting ready for a particular trip that can see you away from your house for about a month or so, then it is necessary for you to take the help of travel vaccinations. Not ...
  • The Work Of The Ophthalmology Specialist
  • When we consider ophthalmology as a branch of science, it is actually about the treatment as well as getting to diagnose the different kinds of diseases and the disorder that is to ...
  • The Process Of Dental Implants And The Subsequent Recovery
  • In the United States of America, the fear of going to a dentist happens to rank number one on the list of children as well as adults. Most of the people are actually concerned when ...
  • The medication that can help the rural population
  • It is not always that you get to see world class hospitals in the rural areas, be it America or any other country. Hence, it is important that people actually take the help of tele-medication, ...
  • The Future of Telemedicine & Its Use
  • When talking about telemedicine, you do get to realize that it is the healthcare of the future. Most of the people do not realize the implications, and for more so the time, telemedicine ...

Get Updates

Share This Post

Recent Posts

© 2021 RnR Company Profiles. All rights reserved.